Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 23,458 shares at $19.33 ($453K) on 2021-02-25, disclosed to the SEC on 2021-02-25.
Seasonal sale ($453k) by President & CEO — this insider has traded CARA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.33 | 11,729 | $227K | 50.0% |
| 2 | $19.33 | 11,729 | $227K | 50.0% |
| Total | $19.33 avg | 23,458 | $453K | 100% |
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |
| CARA | SELL | 2020-12-29 | $80K | — | Filing → |